Research

Hormonal

Administration of antiangiogenic agents (specifically angiostatin, endostatin, or TNP-470) induces dose-dependent, reversible weight loss and adipose tissue loss in obese animal models without reducing food intake.

This research suggests that blocking the blood vessel growth required for fat tissue expansion can cause fat loss even if you eat the same amount of food. While this is currently only proven in mice using specific drugs (like angiostatin or endostatin), it implies that future treatments might target the blood supply to fat cells rather than just focusing on diet and exercise.

ModerateSupportsMEDIUM confidence
administration of angiostatin, endostatin, and TNP-470 in both genetically obese and high-calorie diet–fed mice results in a dose-dependent and reversible weight reduction as well as adipose tissue loss without significantly affecting food intakes
Yihai Cao · Journal of Clinical Investigation · 2007

Why this rating

Evidence is derived from animal models (genetically obese and diet-induced mice); human clinical data is not provided in this review.

Source

Angiogenesis modulates adipogenesis and obesity

Yihai Cao · Journal of Clinical Investigation · 2007

DOI 10.1172/jci32239

narrative_reviewCited 733×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →